ACE2 and viral infectious disease: Moreover, studies on the biology of viral infection and clinical disease management have demonstrated that differences in COVID-19 prevalence and severity are associated with the high affinity of COVID-19 S protein for ACE2, suggesting that populations with higher expression of ACE2 might be more susceptible to COVID-19 infection [51,52] (Figure 2).